Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Clinical Investigation

• Publication date

  2001-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI11273PMID 11306601PMCID PMC199554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload

  2001cited by this paper
• Cardiac fibrosis in mice lacking brain natriuretic peptide.

  2000influential reference
• ABC of heart failure.

  2000cited by this paper
• Cellular and functional defects in a mouse model of heart failure.

  2000cited by this paper
• Effects of indapamide in rats with pressure overload left ventricular hypertrophy.

  2000cited by this paper
• Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese.

  2000cited by this paper
• A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function.

  2000cited by this paper
• ABC of heart failure. Pathophysiology.

  2000cited by this paper
• Raised blood pressure, not renin-angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats.

  2000cited by this paper
• Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy.

  2000cited by this paper
• Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes.

  2000cited by this paper
• Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.

  1999cited by this paper
• Extracellular Signal-regulated Protein Kinase Activation Is Required for the Anti-hypertrophic Effect of Atrial Natriuretic Factor in Neonatal Rat Ventricular Myocytes*

  1999cited by this paper
• Signaling pathways for cardiac hypertrophy and failure.

  1999cited by this paper
• Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.

  1999cited by this paper
• Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases.

  1999cited by this paper
• Hormones and hemodynamics in heart failure.

  1999cited by this paper
• RENIN–ANGIOTENSIN SYSTEM STIMULATES CARDIAC AND RENAL DISORDERS IN TSUKUBA HYPERTENSIVE MICE

  1999cited by this paper
• Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans.

  1999cited by this paper
• Measurement and significance of circulating natriuretic peptides in cardiovascular disease.

  1998cited by this paper
• Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells*

  1998cited by this paper
• Lessons from rat models of hypertension: from Goldblatt to genetic engineering.

  1998cited by this paper
• Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family*

  1998cited by this paper
• Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.

  1998cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.

  1997cited by this paper
• Physiological regulation of blood pressure and kidney function by guanylyl cyclase isoforms.

  1997cited by this paper
• Cardiac hypertrophy: Old concepts, new perspectives

  1997cited by this paper
• Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.

  1997cited by this paper
• Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.

  1997cited by this paper
• Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

  1997cited by this paper
• Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

  1997influential reference
• Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.

  1997cited by this paper
• Role of atrial natriuretic factor in volume control.

  1996influential reference
• Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

  1996cited by this paper
• Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs.

  1996cited by this paper
• Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.

  1996cited by this paper
• Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes.

  1996cited by this paper
• Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes.

  1996cited by this paper
• New York, New York, USA

  1996cited by this paper
• A noninvasive computerized tail-cuff system for measuring blood pressure in mice.

  1995cited by this paper
• Clinical misconceptions dispelled by epidemiological research.

  1995cited by this paper
• Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.

  1995cited by this paper
• Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium.

  1995cited by this paper
• Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension

  1995cited by this paper
• Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide

  1995cited by this paper
• The Mitogen-activated Protein Kinase Kinase MEK1 Stimulates a Pattern of Gene Expression Typical of the Hypertrophic Phenotype in Rat Ventricular Cardiomyocytes (*)

  1995cited by this paper
• Textbook of fetal physiology

  1994cited by this paper
• Physiology of natriuretic peptides

  1994cited by this paper
• ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice.

  1994cited by this paper
• In vivo murine cardiac hypertrophy : a novel model to identify genetic signaling mechanisms that activate an adaptive physiological response

  1993cited by this paper
• Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

  1993cited by this paper
• HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy.

  1993cited by this paper
• Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP.

  1993cited by this paper
• In search of the optimized excimer laser angioplasty system.

  1993cited by this paper
• Ventricular Expression of Brain Natriuretic Peptide in Hypertrophic Cardiomyopathy

  1993cited by this paper
• Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy.

  1992cited by this paper
• Atrial Natriuretic Polypeptide as a Novel Antigrowth Factor of Endothelial Cells

  1992cited by this paper
• Erratum: Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy (Proc. Natl. Acad. Sci. USA (September 1991) 88 (8277-8281))

  1991cited by this paper
• Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy

  1991cited by this paper
• Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy

  1991cited by this paper
• Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.

  1990cited by this paper
• Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.

  1989cited by this paper
• Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR.

  1989cited by this paper
• Myocardial recruitment during ANF mRNA increase with volume overload in the rat.

  1986influential reference
• Myosin heavy chain mRNA during the development and regression of myocardial hypertrophy.

  1984cited by this paper
• Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.

  1982cited by this paper
• Cardiac hypertrophy and antihypertensive therapy.

  1977cited by this paper

• Expression and Regulation of Npr1 Gene Coding for Natriuretic Peptide Receptor-A in Hypertrophied Heart: Mechanisms and Therapeutic Implications

  2026cites this paper
• Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling

  2025cites this paper
• Unveiling the systemic impact of airborne microplastics: Integrating breathomics and machine learning with dual-tissue transcriptomics.

  2025cites this paper
• Molecular Mediators of the Cardiac Benefits of Exercise.

  2025cites this paper
• Triiodo-L-thyronine (T3) downregulates Npr1 gene (coding for natriuretic peptide receptor-A) transcription in H9c2 cells: involvement of β-AR-ROS signaling

  2024cites this paper
• The role of phosphodiesterase 9A inhibitors in heart failure

  2024cites this paper
• The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease

  2024cites this paper
• Phosphorylation-Dependent Regulation of Guanylyl Cyclase (GC)-A and Other Membrane GC Receptors.

  2024cites this paper
• Natriuretic peptides potentiate cardiac hypertrophic response to noradrenaline in rats.

  2023cites this paper
• Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit

  2023cites this paper
• Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.

  2023cites this paper
• Protective effects of calorie restriction and 17-β estradiol on cardiac hypertrophy in ovariectomized obese rats

  2023cites this paper
• Thyroid hormone induces restrictive cardiomyopathy in β1-adrenoceptor knockout mice.

  2023cites this paper
• Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics

  2023cites this paper
• Investigating the role of NPR1 in dilated cardiomyopathy and its potential as a therapeutic target for glucocorticoid therapy

  2023cites this paper
• Impact of Prenatal Alcohol Exposure on the Development and Myocardium of Adult Mice: Morphometric Changes, Transcriptional Modulation of Genes Related to Cardiac Dysfunction, and Antioxidant Cardioprotection

  2023cites this paper
• The Natriuretic Peptide System: A Single Entity, Pleiotropic Effects

  2023cites this paper
• NPPA/atrial natriuretic peptide is an extracellular modulator of autophagy in the heart

  2022cites this paper
• Secretome of Stressed Peripheral Blood Mononuclear Cells Alters Transcriptome Signature in Heart, Liver, and Spleen after an Experimental Acute Myocardial Infarction: An In Silico Analysis

  2022cites this paper
• Neferine attenuates doxorubicin‐induced fibrosis and hypertrophy in H9c2 cells

  2022cites this paper
• Natriuretic peptide pathways in heart failure: further therapeutic possibilities

  2022cites this paper
• Brain Natriuretic Peptide Protects Cardiomyocytes from Apoptosis and Stimulates Their Cell Cycle Re-Entry in Mouse Infarcted Hearts

  2022cites this paper
• Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure

  2021cites this paper
• Guanylyl cyclase‐A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice

  2021cites this paper
• Cardiac natriuretic peptide deficiency sensitizes the heart to stress induced ventricular arrhythmias via impaired CREB signaling.

  2021cites this paper
• Lower B‐type natriuretic peptide levels predict left ventricular concentric remodelling and insulin resistance

  2021cites this paper
• Recombinant Soluble Corin Improves Cardiac Function in Mouse Models of Heart Failure

  2021cites this paper
• The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications.

  2021cites this paper
• Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

  2021cites this paper
• Age- and sex-dependent differences in extracellular matrix metabolism associate with cardiac functional and structural changes.

  2020cites this paper
• Atrial and Brain Natriuretic Peptides

  2020cites this paper
• Translational studies of cardiac non-coding RNAs

  2020cites this paper
• Early Cardiac Remodeling Promotes Tumor Growth and Metastasis

  2020cites this paper
• Involvement of Histamine 2 Receptor in Alpha 1 Adrenoceptor Mediated Cardiac Hypertrophy and Oxidative Stress in H9c2 Cardio Myoblasts

  2020cites this paper
• Atrial Natriuretic Peptide

  2020cites this paper
• Function and regulation of corin in physiology and disease.

  2020cites this paper
• Multiplicity of Nitric Oxide and Natriuretic Peptide Signalling in Heart Failure.

  2020cites this paper
• Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage.

  2020cites this paper
• Genetic Dissection of a Super Enhancer Controlling the Nppa-Nppb Cluster in the Heart.

  2020cites this paper
• BAOXIN Granules Protected Mouse Model With Elevated Afterload From Cardiac Hypertrophy by Suppressing Both Inflammatory Reaction and Collagen Deposition

  2019cites this paper
• Atrial and brain natriuretic peptides: Hormones secreted from the heart.

  2019cites this paper
• Translational science: Newly emerging science in biology and medicine — Lessons from translational research on the natriuretic peptide family and leptin —

  2019cites this paper
• Natriuretic Peptides in Cardiac Anesthesia and Intensive Care.

  2019cites this paper
• Tuscany Sangiovese grape juice imparts cardioprotection by regulating gene expression of cardioprotective C-type natriuretic peptide

  2019cites this paper
• Hypertensive Heart Disease and Obesity: A Review.

  2019cites this paper
• Blood Pressure-Associated Genetic Variants in the Natriuretic Peptide Receptor 1 Gene Modulate Guanylate Cyclase Activity.

  2019cites this paper
• Pregnancy-Associated Cardiac Hypertrophy in Corin-Deficient Mice: Observations in a Transgenic Model of Preeclampsia.

  2019cites this paper
• Genetic Causes of Cardiac Disease

  2019cites this paper
• Cardiovascular Pleiotropic Effects of Natriuretic Peptides

  2019cites this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019influential citation
• Immunolocalization of natriuretic peptides and their receptors in goat (Capra hircus) heart

  2018cites this paper
• Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.

  2018cites this paper
• MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A

  2018cites this paper
• Natriuretic Peptides and Normal Body Fluid Regulation.

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• Hemodynamic Adaptive Mechanisms in Heart Failure

  2018cites this paper
• Mutual Homeostatic Regulation Between Natriuretic Peptides And Mineralocorticoids In The Cardiovascular System

  2018cites this paper
• TGF-b1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II

  2018cites this paper
• Novel function of α1D L-type calcium channel in the atria.

  2017cites this paper
• Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines

  2017cites this paper
• A Glutamate-Substituted Mutant Mimics the Phosphorylated and Active Form of Guanylyl Cyclase-A

  2017cites this paper
• Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1

  2017cites this paper
• Effects of wildtype and mutant forms of atrial natriuretic peptide on L-type Ca2+ current in mouse atrial myocytes

  2016cites this paper
• Estudios Moleculares y Celulares del Sistema de Endotelinas en Cáncer Colorectal

  2016cites this paper
• Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during β-adrenergic receptor activation-induced hypertrophic growth in rats.

  2016cites this paper
• Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?

  2016cites this paper
• When Sweet Turns Salty: Glucose-Induced Suppression of Atrial Natriuretic Peptide by MicroRNA-425.

  2016cites this paper
• Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease

  2016cites this paper
• Therapeutic Molecular Phenotype of &bgr;-Blocker–Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy

  2015cites this paper
• Current Understanding of the Compensatory Actions of Cardiac Natriuretic Peptides in Cardiac Failure: A Clinical Perspective.

  2015cites this paper
• Cardiac nonmyocytes in the hub of cardiac hypertrophy.

  2015cites this paper
• Systemic, but not cardiomyocyte-specific, deletion of the natriuretic peptide receptor guanylyl cyclase A increases cardiomyocyte number in neonatal mice

  2015cites this paper
• The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment

  2015cites this paper
• B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension

  2015cites this paper
• Natriuretic Peptides and Cardiometabolic Health.

  2015cites this paper
• Nandrolone decanoate induces cardiac and renal remodeling in female rats, without modification in physiological parameters: The role of ANP system.

  2015cites this paper
• Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events

  2015cites this paper
• Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.

  2015cites this paper
• The Role of Neurohumoral Activation in Cardiac Fibrosis and Heart Failure

  2015cites this paper
• β‐Blockers have differential effects on the murine asthma phenotype

  2015cites this paper
• Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).

  2015cites this paper
• Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB

  2015cites this paper
• Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner.

  2014cites this paper
• Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

  2014cites this paper
• Atrial natriuretic factor receptor guanylate cyclase, ANF-RGC, transduces two independent signals, ANF and Ca2+

  2014cites this paper
• Differential gene expression of C-type natriuretic peptide and its related molecules in dilated and ischemic cardiomyopathy. A new option for the management of heart failure.

  2014cites this paper
• Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis

  2014cites this paper
• Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C

  2014cites this paper
• PDE5 inhibitor efficacy is estrogen dependent in female heart disease.

  2014cites this paper
• The Roles of Phosphodiesterase (PDE) 3A and 3B as Regulators of Cardiac Function in Disease

  2014cites this paper
• Ageing in the zebrafish heart

  2014cites this paper
• A Temporal Characterization of the TAC and MI models of Heart Failure in CD-1 Mice

  2014cites this paper
• Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.

  2014cites this paper
• Hypertensive Heart Disease and Obesity: A Complex Interaction Between Hemodynamic and Not Hemodynamic Factors

  2014cites this paper
• Aortic Remodeling After Transverse Aortic Constriction in Mice Is Attenuated With AT1 Receptor Blockade

  2013cites this paper
• Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts

  2013cites this paper
• cGMP-dependent protein kinases (cGK).

  2013cites this paper
• Protein kinase G I and heart failure: Shifting focus from vascular unloading to direct myocardial antiremodeling effects.

  2013cites this paper
• Vasoactive peptides and the pathogenesis of pulmonary hypertension: role and potential therapeutic application.

  2013cites this paper
• NATRIURETIC PEPTIDES MODULATE HEART RATE, ELECTRICAL CONDUCTION AND ARRHYTHMOGENSIS IN VIVO

  2013cites this paper